Article
Predicted deleterious variants in ABCA1, LPL, LPA and KIF6 are associated with statin response and adverse events in patients with familial hypercholesterolemia and disturb protein structure and stability.
Pharmacogenetics and genomics - 1 Jun 2024
Dagli-Hernandez Carolina, Ferreira Glaucio Monteiro, Freitas Renata Caroline Costa de, Borges Jessica Bassani, Oliveira Victor Fernandes de, Gonçalves Rodrigo Marques, Faludi Andre Arpad, Marçal Elisangela da Silva Rodrigues, Bastos Gisele Medeiros, Bortolin Raul Hernandes, Hirata Mario Hiroyuki, Hirata Rosario Dominguez Crespo
Abstract excerpt
OBJECTIVES: This study explored the association of deleterious variants in pharmacodynamics (PD) genes with statin response and adverse effects in patients with familial hypercholesterolemia (FH) and analyzed their potential effects on protein structure and stability. METHODS: Clinical and laboratory data were obtained from 144 adult FH patients treated with statins. A panel of 32 PD genes was analyzed by...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
